Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers

Colorectal cancer (CRC) is one of the leading causes of cancer deaths worldwide. Recent advances in recombinant DNA technology have led to the development of numerous therapeutic antibodies as major sources of blockbuster drugs for CRC therapy. Simultaneously, increasing numbers of therapeutic targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Kyusang, Yoon, Jin Hwan, Lee, Ji Hyun, Lee, Sukmook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824816/
https://www.ncbi.nlm.nih.gov/pubmed/33466394
http://dx.doi.org/10.3390/biomedicines9010039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824816/
https://www.ncbi.nlm.nih.gov/pubmed/33466394
http://dx.doi.org/10.3390/biomedicines9010039

Ejemplares similares